NKGen Biotech, Inc.
NKGNDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SNK01 | Phase 2 | Moderate Alzheimer Disease | - | - |
Frequently asked questions
What is in NKGen Biotech, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in NKGen Biotech, Inc.'s (NKGN) pipeline across Phase 2. Its lead program is SNK01 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NKGen Biotech, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NKGen Biotech, Inc. (NKGN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NKGN biotech catalysts?→
Add NKGN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NKGen Biotech, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.